Results 1 to 10 of about 5,418,281 (396)

Second opinions in medical oncology [PDF]

BMC Palliative Care, 2020
Background The current study aimed to further our understanding of second opinions among medical oncology patients by examining the proportion of patients who sought a second opinion about their cancer treatment, and why.
Ian Olver, Mariko Carey, Jamie Bryant, Allison Boyes, Tiffany Evans, Rob Sanson-Fisher   +5 more
doaj   +6 more sources

Performance of Large Language Models on Medical Oncology Examination Questions.

JAMA Netw Open
This cross-sectional study evaluates the accuracy of large language model (LLM) answers to examination-style multiple choice medical oncology questions and assessed whether errors in LLM responses would be likely to cause harm.
Longwell JB, Hirsch I, Binder F, Gonzalez Conchas GA, Mau D, Jang R, Krishnan RG, Grant RC.   +7 more
europepmc   +2 more sources

Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology

Ca-A Cancer Journal for Clinicians, 2017
Answer questions and earn CME ...
Cecilia G Ethun, Mehmet A Bilen, Shishir K Maithel   +2 more
exaly   +2 more sources

Medical oncology in India: Workload, infrastructure, and delivery of care

Indian Journal of Medical and Paediatric Oncology, 2019
Background: The growing burden of cancer within India has implications across the health system including operational delivery of cancer care and planning for human health resources.
Manju Sengar, Adam Fundytus, Wilma M Hopman, Hemant Malhotra, Sudeep Gupta, C S Pramesh, Nazik Hammad, Richard Sullivan, Verna Vanderpuye, Bostjan Seruga, Gilberto Lopes, Michael D Brundage, Christopher M Booth   +12 more
doaj   +2 more sources

Impact of the COVID-19 Pandemic on Medical Oncology Workload: A Provincial Review [PDF]

Current Oncology, 2023
(1) Background: Cancer is the leading cause of death in Canada, with significant resource limitation impacting the delivery of cancer care nationwide.
Margaret Sheridan, Bruce Colwell, Nathan W. D. Lamond, Robyn Macfarlane, Daniel Rayson, Stephanie Snow, Lori A. Wood, Ravi Ramjeesingh   +7 more
doaj   +2 more sources

Clinical practice guidelines for cancer-related fatigue in China (2021 edition) [PDF]

Zhongguo aizheng zazhi, 2021
Cancer has become one of the most important public issues which seriously influence the health condition of Chinese population. The cancer-related fatigue has drawn great attention.
Tumor Support and Rehabilitation Therapy Group, the Oncology Committee of Chinese Medical Association
doaj   +1 more source

Guidelines for breast cancer diagnosis and treatment by China Anti-cancer Association (2024 edition) [PDF]

Zhongguo aizheng zazhi, 2023
According to the latest data released by the International Agency for Research on Cancer of the World Health Organization (WHO), breast cancer has become the malignant tumor with the highest incidence rate around the world, seriously endangering the ...
The Society of Breast Cancer China Anti-Cancer Association, Breast Oncology Group of the Oncology Branch of the Chinese Medical Association
doaj   +1 more source

Clinical Practice Guidelines for Immune Checkpoint Inhibitor Therapy in Gynecological Tumors

Xiehe Yixue Zazhi, 2021
Immune checkpoint inhibitors (ICI) have shown efficacy for some patients with gynecological tumors, which are mainly used to treat persistent, recurrent, or metastatic patients.
Gynecological Oncology Society of Chinese Medical Association
doaj   +1 more source

Global Oncology Medical Diplomacy Working Group Inaugural Meeting: Defining Worldwide Barriers to Germline Genomics in Cancer Prevention and Management

Annals of Global Health, 2023
We convened an international working group to examine the issues that challenge equity and inclusion in genetic medicine. Specifically, 72 internationally known experts in oncology and cancer genetics from 34 countries (the Global Oncology Medical ...
Ghassan K. Abou-Alfa, Larry Norton, The Global Oncology Medical Diplomacy Working Group   +2 more
doaj   +1 more source

New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Clinical and Translational Oncology, 2022
Non-small cell lung cancer (NSCLC) presents the greatest number of identified therapeutic targets, some of which have therapeutic utility. Currently, detecting EGFR , BRAF , KRAS and MET mutations, ALK , ROS1 , NTRK and RET translocations, and PD-L1 ...
D. Isla, M. Lozano, L. Paz-Ares, C. Salas, J. de Castro, E. Conde, E. Felip, J. Gómez-Román, P. Garrido, A. Enguita   +9 more
semanticscholar   +1 more source